Endometriosis and polycystic ovary syndrome (PCOS) are two of the most common conditions affecting women of reproductive age in South Africa — and both can significantly impair fertility. Together, they account for a substantial proportion of the infertility diagnoses made at fertility clinics across the country. Yet despite their prevalence and medical significance, the intersection of these conditions and medical aid cover remains poorly
understood by many patients. If you have been diagnosed with endometriosis or PCOS, or suspect you may have either condition, understanding what your medical aid may cover — and what it almost certainly won’t — is essential information for planning your fertility journey.
Endometriosis and Fertility: The Clinical Picture
Endometriosis is a chronic inflammatory condition in which tissue resembling the uterine lining grows outside the uterus — on the ovaries, fallopian tubes, bowel, bladder, or peritoneal lining. It affects an estimated 10% to 15% of women of reproductive age globally. In South Africa, as globally, the condition is significantly underdiagnosed, with many women spending years seeking answers for symptoms that include pelvic pain, painful periods, pain
during intercourse, and — relevantly for this discussion — infertility. Endometriosis can impair fertility in several ways: by causing adhesions that distort pelvic anatomy and block fallopian tubes, by creating endometriomas (ovarian cysts) that damage ovarian reserve, and through inflammatory mechanisms that affect egg quality and
implantation.
What Medical Aids May Cover for Endometriosis
The cover available for endometriosis depends on the nature of the presentation and the treatment required:
Diagnostic investigations — including gynaecological consultations, ultrasounds, and in some cases diagnostic laparoscopy — may be partially funded through a member’s specialist or day-to-day benefits, depending on the plan.
Surgical treatment — laparoscopic surgery to remove endometriotic lesions, drain endometriomas, or restore normal pelvic anatomy — may qualify for in-hospital benefit cover. Where surgery is clinically indicated and medically motivated, schemes should fund it under appropriate benefit codes. In some cases, surgical treatment may attract PMB-level cover depending on the clinical coding and the specific DTP applicable.
Medical management — hormonal therapies used to suppress endometriosis (such as GnRH analogues, combined oral contraceptives, or progestin-only therapy) may be partially covered under chronic medicine benefits, depending on the scheme and plan.
IVF for endometriosis-related infertility — where endometriosis has resulted in infertility, a fertility specialist may recommend IVF. Whether this is covered depends entirely on the member’s specific plan benefits. It is not covered as a PMB consequence of endometriosis. For a broader understanding of PMBs and their intersection with fertility-related conditions, read: Understanding PMBs and Fertility-Related Conditions.
PCOS and Fertility: The Clinical Picture
Polycystic ovary syndrome is the most common endocrine disorder in women of reproductive age, affecting an estimated 8% to 13% of this population globally. In South Africa, PCOS is frequently encountered in fertility clinics and is a leading cause of anovulatory infertility — infertility resulting from absent or irregular ovulation.
PCOS is characterised by a combination of features that may include irregular or absent menstrual cycles, excess androgen activity (presenting as acne, unwanted hair growth, or hair loss), and polycystic-appearing ovaries on ultrasound. Insulin resistance, weight challenges, and metabolic health issues are commonly associated.
What Medical Aids May Cover for PCOS
PCOS is listed on the Chronic Disease List (CDL) as a condition that qualifies for PMB-level cover under specific metabolic criteria — primarily insulin resistance managed with medications such as metformin. This means:
Metformin (and similar medications for insulin resistance management in PCOS) may be covered under your CDL benefit at scheme tariff if you qualify for CDL registration. This is worth pursuing with your doctor and scheme.
Fertility-related investigations — hormonal panels, ultrasounds — may be partially funded through specialist or day-to-day benefits. The extent of cover depends on your plan.
Ovulation induction treatment — clomiphene citrate, letrozole, or injectable gonadotrophins used to stimulate ovulation in PCOS — may or may not be covered depending on whether your scheme includes specific fertility benefits. These medications, while less expensive than IVF stimulation protocols, can still add to your treatment costs.
IVF for PCOS-related infertility — if first-line ovulation induction fails, IVF may be recommended. As with endometriosis, whether IVF is covered depends on your scheme’s voluntary fertility benefits. The PCOS diagnosis itself does not trigger IVF cover through the PMB framework.
Getting the Most From Your Cover
For both endometriosis and PCOS patients, there are practical steps that can optimise the value of existing medical aid benefits:
- Ensure your diagnosis is correctly coded by your treating specialist. Incorrect coding is a common reason for claim rejections.
- Ask your doctor whether CDL registration for PCOS (where applicable) is appropriate for your case.
- Request pre-authorisation for any surgical procedures in writing before they occur.
- Understand which benefit category applies to each element of your treatment — in- hospital benefit, specialist benefit, chronic medicine benefit, or a voluntary fertility benefit.
- Keep records of all communications with your scheme regarding fertility-related claims.
For detailed guidance on navigating these conversations, read: Questions to Ask Your Medical Aid Before Starting Fertility Treatment.
The Advocacy Gap
Women with endometriosis and PCOS in South Africa face a double challenge: they manage complex, often under-recognised conditions while simultaneously navigating a medical aid system that provides inconsistent and frequently inadequate support. Advocacy for better recognition of these conditions within the PMB framework — and within workplace health policies — is urgently needed. It is worth noting that endometriosis, in particular, carries a significant diagnostic delay — on average, seven to ten years from symptom onset to diagnosis. By the time a diagnosis is made, the impact on fertility may already be significant, and the emotional toll on patients is substantial. As discussed in The Emotional and Financial Burden of Infertility, this journey deserves to be acknowledged and supported — not simply managed as a billing exercise.
Frequently Asked Questions
Does medical aid cover endometriosis surgery in South Africa?
Laparoscopic surgery for endometriosis may be covered under your scheme’s in-hospital benefit, subject to pre-authorisation and clinical motivation. In some cases, it may qualify for PMB cover. Confirm with your scheme before proceeding.
Is PCOS on the Chronic Disease List in South Africa?
PCOS appears on the CDL but only under specific metabolic criteria (insulin resistance). Not all PCOS presentations qualify for CDL registration. Your doctor will need to assess whether your case meets the clinical criteria for CDL cover.
Can I still access IVF with endometriosis?
Yes. IVF is an effective treatment for endometriosis-related infertility, and many women with endometriosis successfully conceive through IVF. Whether IVF is covered by your medical aid depends on your specific plan benefits — not your diagnosis.
Does having PCOS or endometriosis affect my ability to get medical aid?
Schemes cannot refuse membership on the grounds of a pre-existing condition under the Medical Schemes Act, although waiting periods may apply for certain benefits related to pre- existing conditions.
